We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

205 hedge funds and large institutions have $1.98B invested in Myriad Genetics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 65 increasing their positions, 74 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

785% more call options, than puts

Call options by funds: $7.18M | Put options by funds: $811K

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

4% more funds holding

Funds holding: 197 → 205 (+8)

0.53% more ownership

Funds ownership: 98.03% → 98.56% (+0.53%)

8% less capital invested

Capital invested by funds: $2.16B → $1.98B (-$175M)

12% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 74

Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
3.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
65
Reduced
74
Closed
22
Calls
$7.18M
Puts
$811K
Net Calls
+$6.37M
Net Calls Change
-$1.84M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$19.7M
2
CCM
Camber Capital Management
Massachusetts
+$19.2M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$8.22M
4
Bank of America
Bank of America
North Carolina
+$6.91M
5
Artisan Partners
Artisan Partners
Wisconsin
+$4.25M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$22.7M
2
Goldman Sachs
Goldman Sachs
New York
-$7.08M
3
State Street
State Street
Massachusetts
-$5.48M
4
N
Nuveen
North Carolina
-$4.44M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$4.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$373M +$2.89M +113,042 +0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$226M -$4.43M -172,928 -2%
EARNEST Partners
3
EARNEST Partners
Georgia
$158M -$1.01M -39,305 -0.6%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$128M +$19.7M +770,460 +18%
State Street
5
State Street
Massachusetts
$106M -$5.48M -214,178 -5%
CCM
6
Camber Capital Management
Massachusetts
$88.2M +$19.2M +750,000 +27%
Bank of America
7
Bank of America
North Carolina
$69.5M +$6.91M +269,887 +11%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$64.5M -$1.92M -74,859 -3%
Artisan Partners
9
Artisan Partners
Wisconsin
$58.6M +$4.25M +165,951 +8%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$47.5M -$538K -21,030 -1%
PHS
11
PFM Health Sciences
California
$47.4M -$3.67M -143,324 -7%
DGI
12
Disciplined Growth Investors
Minnesota
$47.2M +$716K +27,988 +2%
GCM
13
Glenview Capital Management
New York
$43.8M +$1.47M +57,262 +3%
Goldman Sachs
14
Goldman Sachs
New York
$39.6M -$7.08M -276,820 -15%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$36.5M +$483K +18,879 +1%
Northern Trust
16
Northern Trust
Illinois
$31.3M -$1.05M -41,159 -3%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$23.3M -$210K -8,217 -0.9%
SEI Investments
18
SEI Investments
Pennsylvania
$22.4M +$2.31M +90,449 +11%
Charles Schwab
19
Charles Schwab
California
$20.4M +$445K +17,390 +2%
JP Morgan Chase
20
JP Morgan Chase
New York
$19.9M +$1.98M +77,552 +11%
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$19M +$45.6K +1,783 +0.2%
Ameriprise
22
Ameriprise
Minnesota
$18.2M +$142K +5,562 +0.8%
Invesco
23
Invesco
Georgia
$16.6M -$3.35M -130,960 -17%
Morgan Stanley
24
Morgan Stanley
New York
$14.6M +$3.09M +120,611 +26%
Principal Financial Group
25
Principal Financial Group
Iowa
$14.5M -$642K -25,077 -4%
1
2 3 4 5

MYGN Hedge Fund Activity: Q1 2022 in Review

205 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2022, worth a combined $1.98B — down 8.1% from $2.16B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MYGN positions and 22 closed out — a net gain of 9 holders — while 65 added to existing stakes and 74 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $19.7M. The largest seller was Millennium Management, cutting an estimated $22.7M.

  • 205 institutional investors held Myriad Genetics (MYGN) as of Q1 2022, up from 197 in Q4 2021.
  • Funds reported $1.98B of Myriad Genetics stock for Q1 2022, down 8.1% quarter-over-quarter.
  • 31 funds opened new Myriad Genetics positions in Q1 2022 and 22 closed out, a net change of +9 holders.
  • The largest Myriad Genetics buyer in Q1 2022 was Wellington Management Group, an estimated $19.7M added.
  • The largest Myriad Genetics seller in Q1 2022 was Millennium Management, an estimated $22.7M sold.

Based on aggregated 13F filings for Q1 2022.